A recent major concern about the safety of Hepatitis B vaccines in China has put manufacturers and the health authorities under a spotlight and threatened progress in significantly lowering Hep B infection rate two decades after China added the Hep B vaccine into the newborn immunization plan in 1992. Last month, Chinese media relayed suspicions […]
The Food and Drug Administration (FDA) has been subject to frequent criticism for its lax oversight of food safety, and particularly of food additives. However, this morning the agency stepped out ahead of most of its international peers, submitting for public comment a new determination that would effectively remove partially hydrogenated oils (PHOs), the primary […]
Source: CDC A study published in Pediatrics by researchers at Nationwide Children’s Hospital in Columbus, OH has been in the news (ABC News; Wall Street Journal; New York Times) after they found that 72% of the breast milk samples they purchased online contained infection-causing bacteria. This comes after increased awareness and promotion of […]
The advent of big data has forced a sea change throughout the scientific research enterprise, shaking the industry’s fundamental attitude towards the data themselves. Data is now understood as the currency of research. Consequently, industry is warming to the new reality that legal norms once considered to drive business – confidential commercial information, trade secrets […]
This post was written by Holly Jarman, Research Assistant Professor at the University of Michigan. For more information about this post, please contact firstname.lastname@example.org. The original post can be found at the Huffington Post. The government’s disappointing U-turn over plain packaging of tobacco has dealt a blow to campaigners and shows a government attempting to […]
Posted in Uncategorized; Tagged: blog, FDA, georgetown, global health, health legislation, health reform, national health law, NCDs, non-communicable diseases, O'Neill Institute, tobacco, tobacco control.
A Georgetown public health expert and attorney examines what the FDA must do to prevail. WASHINGTON — When the U.S. Food and Drug Administration (FDA) imposes new graphic warning labels for tobacco products, they can survive a First Amendment challenge if they depict health consequences and their effectiveness is supported by adequate scientific evidence, says […]
Posted in Uncategorized; Tagged: blog, FDA, food safety, georgetown, global health, health legislation, health reform, national health law, non-communicable diseases, O'Neill Institute, Supreme Court, tobacco, tobacco control.
In honor of the O’Neill Institute’s 100th blog post, we present a “top ten” list of some of our most memorable posts: 1. The Supreme Court Upholds the Affordable Care Act Upheld: The Individual Mandate is a Tax. States Have a Choice Whether to Expand Medicaid (June 2012). 2. New York’s Ban on Large Sodas: […]
Posted in Uncategorized; Tagged: 100th post, ACA, AIDS, blog, China, FCTC, FDA, Global Health Intiative, global health law, Gostin, health reform, HIV, human rights, mark dybul, mental health, national health law, NCDs, non-communicable diseases, O'Neill Institute, Supreme Court, tobacco control, UN, UNAIDS, WHO, World Health Assembly, World Health Organization.
This post was written by Alberto Alemanno, O’Neill Institute Scholar . It was originally published at http://albertoalemanno.eu/category/blog. Any questions or comments about this post can be directed to email@example.com. Barely a day goes by in China without news of yet another food safety scandal. This situation is seriously affecting not only the Chinese’s sentiment of […]
On April 24, the O’Neill Institute hosted a presentation by two visiting scholars from the Shanghai Food and Drug Administration (SHFDA). Mr. Ji Chen is the Deputy Director of the Department of Drug Sale and Marketing Control at the SHFDA headquarters. Mr. Junhua Wu is the Senior Drug Inspection Officer of the Pudong Branch of the SHFDA.
A committee formed by the Institute of Medicine (IOM), National Academy of Science, and chaired by O’Neill Institute for National and Global Health Law Faculty Director and Georgetown University Law Center Professor Lawrence Gostin has issued a new report, “Countering the Problem of Falsified and Substandard Drugs,” which offers recommendations to the United States and […]
Signup for our mailing list and stay up to date on the latest happenings at The O’Neill Institute
Or sign up for our RSS Feed
The views reflected in this blog are those of the individual authors and do not necessarily represent those of the O’Neill Institute for National and Global Health Law or Georgetown University. This blog is solely informational in nature, and not intended as a substitute for competent legal advice from a licensed and retained attorney in your state or country.